The results of gefitinib in front line treatment of Caucasian patients with NSCLC in the Czech Republic: analysis according to activated mutations location

• Authors: SKŘIČKOVÁ Jana; BORTLÍČEK Zbyněk; HEJDUK Karel; PESEK Milos; KOLEK Vitezslav; KOUBKOVA Leona; TOMÍŠKOVÁ Marcela; ROUBEC Jaromír; HAVEL Libor; SALAJKA František
• Year of publication: 2014
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: This study evaluates treatment outcomes in 127 non-small cell lung cancer (NSCLC) patients from Czech Republic according to activated mutations located in exons 19 (Del 19) and 21 (L858R).